Enantioselective α-benzylation of aldehydes via photoredox organocatalysis

Journal of the American Chemical Society

Volumn 132, Issue 39, 2010, Pages 13600-13603

  Shih, Hui Wen ^a   Vander Wal, Mark N ^a   Grange, Rebecca L ^a   MacMillan, David W C ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; BENZYLATION; DRUG TARGETS; ELECTRON-DEFICIENT; ENANTIOSELECTIVE; FLUORESCENT LIGHT; ORGANOCATALYSIS; ORGANOCATALYSTS;

ENANTIOSELECTIVITY; IRIDIUM; REACTION KINETICS;

ALDEHYDES;

ALDEHYDE; AMINE; ANGIOGENESIS INHIBITOR; BENZYL BROMIDE; IMIDAZOLIDINONE; NATURAL PRODUCT; REAGENT; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ARTICLE; BENZYLATION; CANCER CHEMOTHERAPY; CATALYSIS; CATALYST; CHEMICAL STRUCTURE; CHIRAL CHROMATOGRAPHY; CHIRALITY; DIABETIC RETINOPATHY; DRUG SYNTHESIS; DRUG TARGETING; ENANTIOSELECTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ORGANIC CHEMISTRY; OXIDATION REDUCTION REACTION; PHOTOCATALYSIS; STEREOCHEMISTRY;

ALDEHYDES; CATALYSIS; CRYSTALLOGRAPHY, X-RAY; IMIDAZOLIDINES; IRIDIUM; MODELS, MOLECULAR; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; PHOTOCHEMISTRY; STEREOISOMERISM;

EID: 77957304088     PISSN: 00027863     EISSN: 15205126     Source Type: Journal    
DOI: 10.1021/ja106593m     Document Type: Article

References (37)

1. Evans, D. A., Ennis, M. D., and Mathre, D. J. J. Am. Chem. Soc. 1982, 104, 1737
2. Myers, A. G., Yang, B. H., Chen, H., and Gleason, J. L. J. Am. Chem. Soc. 1994, 116, 9361
3. Seebach, D. and Wasmuth, D. Helv. Chim. Acta 1980, 63, 197
4. Oppolzer, W., Moretti, R., and Thomi, S. Tetrahedron Lett. 1989, 30, 5603
5. Maruoka, K. and Ooi, T. Chem. Rev. 2003, 103, 3013
6. Ooi, T. and Maruoka, K. Angew. Chem., Int. Ed. 2007, 46, 4222
7. Imai, M., Hagihara, A., Kawasaki, H., Manabe, K., and Koga, K. J. Am. Chem. Soc. 1994, 116, 8829
8. Doyle, A. G. and Jacobsen, E. N. J. Am. Chem. Soc. 2005, 127, 62
9. Doyle, A. G. and Jacobsen, E. N. Angew. Chem., Int. Ed. 2007, 46, 3701
10. An intramolecular enamine alkylation strategy has been demonstrated; see
11. Vignola, N. and List, B. J. Am. Chem. Soc. 2004, 126, 450
12. Shaikh, R. R., Mazzanti, A., Petrini, M., Bartoli, G., and Melchiorre, P. Angew. Chem., Int. Ed. 2008, 47, 8707
13. Cozzi, P. G., Benfatti, F., and Zoli, L. Angew. Chem., Int. Ed. 2009, 48, 1313
14. Brown, A. R., Kuo, W.-H., and Jacobsen, E. N. J. Am. Chem. Soc. 2010, 132, 9286
15. Nicewicz, D. A. and MacMillan, D. W. C. Science 2008, 322, 77
16. For recent examples of photoredox catalysis, see
17. Ischay, M. A., Anzovino, M. E., Du, J., and Yoon, T. P. J. Am. Chem. Soc. 2008, 130, 12886
18. Koike, T. and Akita, M. Chem. Lett. 2009, 38, 166
19. Narayanam, J. M. R., Tucker, J. W., and Stephenson, C. R. J. J. Am. Chem. Soc. 2009, 131, 8756
20. Nagib, D. A., Scott, M. E., and MacMillan, D. W. C. J. Am. Chem. Soc. 2009, 131, 10875
21. Du, J. and Yoon, T. P. J. Am. Chem. Soc. 2009, 131, 14604
22. Condie, A. G., González-Go'mez, J. C., and Stephenson, C. R. J. J. Am. Chem. Soc. 2010, 132, 1464
23. Tucker, J. W., Narayanam, J. M. R., Krabbe, S. W., and Stephenson, C. R. J. Org. Lett. 2010, 12, 368
24. Tucker, J. W., Nguyen, J. D., Narayanam, J. M. R., Krabbe, S. W., and Stephenson, C. R. J. Chem. Commun. 2010, 46, 4985
25. Furst, L., Matsuura, B. S., Narayanam, J. M. R., Tucker, J. W., and Stephenson, C. R. J. Org. Lett. 2010, 12, 3104
26. Ischay, M. A., Lu, Z., and Yoon, T. P. J. Am. Chem. Soc. 2010, 132, 8572
27. The racemic homolytic alkylation of stoichiometric enamines using p -nitrobenzyl chloride as radical precursor is known; see: Russell, G. A. and Wang, K. J. Org. Chem. 1991, 56, 3475
28. Flamigni, L., Barbieri, A., Sabatini, C., Ventura, B., and Barigelletti, F. Top. Curr. Chem. 2007, 281, 143
29. 3CN; see: Wayner, D. D. M., Dannenberg, J. J., and Griller, D. Chem. Phys. Lett. 1986, 131, 189
30. 3CN) and the nucleophilic nature of the unsubstituted benzylic radical. For benzyl bromide reduction potential, see: Koch, D. A., Henne, B. J., and Bartak, D. E. J. Electrochem. Soc. 1987, 134, 3062 For benzylic radical nucleophilicity, see: De Vleeschouwer, F., Van Speybroeck, V., Waroquier, M., Geerlings, P., and De Proft, F. Org. Lett. 2007, 9, 2721
31. DFT calculations were performed with the use of B3LYP/6-311+G(2d,2p)// B3LYP/6-31G(d).
32. 2 is a competent photoredox catalyst for these transformations but usually results in lower conversion; for photophysical properties, see: Kalyanasundaram, K. Coord. Chem. Rev. 1982, 46, 159
33. 3)ppy = 2-(2,4-difluorophenyl)-5-trifluoromethylpyridine; dtbbpy = 4,4′-di- tert -butyl-2,2′-dipyridyl; see: Lowry, M. S., Goldsmith, J. I., Slinker, J. D., Rohl, R., Pascal, R. A., Jr., Malliaras, G. G., and Bernhard, S. Chem. Mater. 2005, 17, 5712
34. a values in DMSO, see: Bordwell, F. G. Acc. Chem. Res. 1988, 21, 456 For reduction potentials, see: Wiberg, K. B. and Lewis, T. P. J. Am. Chem. Soc. 1970, 92, 7154
35. Thévenot, D. and Buvet, R. J. Electroanal. Chem. 1972, 39, 429
36. The parent bromomethyl-heterocycles lacking additional substitution (e.g., 2-(bromomethyl)pyrazine) are reported to be unstable; for pyrimidines, see: Brown, D. J. and Waring, P. Aust. J. Chem. 1974, 27, 2251 For pyrazines, see: Sasaki, K., Sugou, K., Miyamoto, K., Hirai, J., Tsubouchi, S., Miyasaka, H., Itaya, A., and Kuroda, Y. Org. Biomol. Chem. 2004, 2, 2852 For triazines, see: Von Angerer, S. Sci. Synth. 2003, 17, 449
37. Matsuoka, H., Nishimura, K., Seike, H., Aono, H., and Murai, M. Preparation of pyridylalkylurea derivatives as angiogenesis inhibitors. U.S. Patent 2008/0161270 A1, July 3, 2008.